The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/show/NCT00403351




Registration number
NCT00403351
Ethics application status
Date submitted
22/11/2006
Date registered
23/11/2006
Date last updated
3/04/2019

Titles & IDs
Public title
Alternative Risk Markers in Coronary Artery Disease (ARMCAD)
Scientific title
Correlation of Multiple Risk Factors With Presence and Severity of Coronary Artery Disease.
Secondary ID [1] 0 0
CP-02/04
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Coronary Artery Disease 0 0
Condition category
Condition code
Cardiovascular 0 0 0 0
Coronary heart disease
Cardiovascular 0 0 0 0
Other cardiovascular diseases

Intervention/exposure
Study type
Observational
Patient registry
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
ARM-CAD 1 - Cross-sectional analysis using coronary angiogram results

ARM-CAD 2 - Prospective cohort for incident cardiovascular events and mortality

Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Extent and severity of angiographic coronary artery disease
Timepoint [1] 0 0
cross-sectional
Primary outcome [2] 0 0
All-cause death or myocardial infarction
Timepoint [2] 0 0
1, 2, 5 years
Primary outcome [3] 0 0
All-cause death, MI or need for cardiac surgery
Timepoint [3] 0 0
1, 2, 5 years
Secondary outcome [1] 0 0
All-cause death
Timepoint [1] 0 0
1, 2, 5 years

Eligibility
Key inclusion criteria
- Adults (18 years or older)

- Male or Female
Minimum age
18 Years
Maximum age
No limit
Gender
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
- Acute coronary syndrome

- Urgent angiography

- Assessment would constitute harm to patient

- Informed consent not obtained

Study design
Purpose
Duration
Cross-sectional
Selection
Timing
Statistical methods / analysis

Recruitment
Recruitment status
Active, not recruiting
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
VIC
Recruitment hospital [1] 0 0
Box Hill Hospital (Eastern Health) - Box Hill
Recruitment hospital [2] 0 0
Caulfield General Medical Centre - Caulfield
Recruitment hospital [3] 0 0
Northern Hospital (Northern Health) - Epping
Recruitment hospital [4] 0 0
Alfred Hospital - Melbourne
Recruitment postcode(s) [1] 0 0
3128 - Box Hill
Recruitment postcode(s) [2] 0 0
- Caulfield
Recruitment postcode(s) [3] 0 0
3076 - Epping
Recruitment postcode(s) [4] 0 0
3004 - Melbourne

Funding & Sponsors
Primary sponsor type
Other
Name
Monash University
Address
Country
Other collaborator category [1] 0 0
Other
Name [1] 0 0
Royal Brompton & Harefield NHS Foundation Trust
Address [1] 0 0
Country [1] 0 0
Other collaborator category [2] 0 0
Other
Name [2] 0 0
IM Medical Ltd, Melbourne
Address [2] 0 0
Country [2] 0 0

Ethics approval
Ethics application status

Summary
Brief summary
Estimating the risk of future cardiovascular events such as death, stroke and myocardial
infarction using traditional risk factors (such as age, gender, smoking, diabetes,
hyperlipidaemia and hypertension) is well accepted in patients with and without existing
cardiovascular disease. These estimates are based on a number of robust observational
studies, including the original Framingham study. While these methods apply reasonably well
on a population level their application to the individual patients is not always
straightforward. In addition, risk charts, such as those published by the Joint British
Societies and American Heart Association, may underestimate risk in certain groups, notably
diabetics and patients of Indo-Asian background, whilst overestimating risk in others (by as
much as 50% in some studies).
Trial website
https://clinicaltrials.gov/show/NCT00403351
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Dipak Kotecha, MB ChB PhD
Address 0 0
Monash University, Royal Brompton Hospital & University of Birmingham
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries

Summary results
Other publications